TENET HEALTHCARE CORP Supplies Expense
TENET HEALTHCARE CORP (THC) reported Supplies Expense of $984.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SuppliesExpense · last filed 2026-07-29
- TENET HEALTHCARE CORP supplies expense for the quarter ending 2026-06-30 was $984.00M, a 5.58% increase year-over-year.
- TENET HEALTHCARE CORP supplies expense for the quarter ending 2026-03-31 was $961.00M, a 5.95% increase year-over-year.
- TENET HEALTHCARE CORP supplies expense for the quarter ending 2025-12-31 was $1.01B, a 8.60% increase year-over-year.
- TENET HEALTHCARE CORP supplies expense for the quarter ending 2025-09-30 was $931.00M, a 5.68% increase year-over-year.
- TENET HEALTHCARE CORP supplies expense for fiscal 2025 was $3.78B, a 3.65% increase from fiscal 2024.
- TENET HEALTHCARE CORP supplies expense for fiscal 2024 was $3.65B, a 1.59% increase from fiscal 2023.
- TENET HEALTHCARE CORP supplies expense for fiscal 2023 was $3.59B, a 9.69% increase from fiscal 2022.
- TENET HEALTHCARE CORP supplies expense for fiscal 2022 was $3.27B, a 1.65% decline from fiscal 2021.
| Period end | Supplies Expense 3 month | Supplies Expense 6 month | Supplies Expense 9 month | Supplies Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $984.00M 10-Q · filed 2026-07-29 | $1.95B 10-Q · filed 2026-07-29 | $2.96B derived: sum of 3 quarters · filed 2026-07-29 | $3.89B derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $961.00M 10-Q · filed 2026-04-30 | $1.97B derived: sum of 2 quarters · filed 2026-04-30 | $2.90B derived: sum of 3 quarters · filed 2026-04-30 | $3.83B derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $1.01B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $1.94B derived: sum of 2 quarters · filed 2026-02-17 | $2.87B derived: sum of 3 quarters · filed 2026-07-29 | $3.78B 10-K · filed 2026-02-17 |
| 2025-09-30 | $931.00M 10-Q · filed 2025-10-28 | $1.86B derived: sum of 2 quarters · filed 2026-07-29 | $2.77B 10-Q · filed 2025-10-28 | $3.70B derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $932.00M 10-Q · filed 2026-07-29 | $1.84B 10-Q · filed 2026-07-29 | $2.77B derived: sum of 3 quarters · filed 2026-07-29 | $3.65B derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $907.00M 10-Q · filed 2026-04-30 | $1.84B derived: sum of 2 quarters · filed 2026-04-30 | $2.72B derived: sum of 3 quarters · filed 2026-04-30 | $3.63B derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $930.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $1.81B derived: sum of 2 quarters · filed 2026-02-17 | $2.72B derived: sum of 3 quarters · filed 2026-02-17 | $3.65B 10-K · filed 2026-02-17 |
| 2024-09-30 | $881.00M 10-Q · filed 2025-10-28 | $1.79B derived: sum of 2 quarters · filed 2025-10-28 | $2.72B 10-Q · filed 2025-10-28 | $3.65B derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $908.00M 10-Q · filed 2025-07-30 | $1.84B 10-Q · filed 2025-07-30 | $2.77B derived: sum of 3 quarters · filed 2026-02-17 | $3.64B derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $928.00M 10-Q · filed 2025-04-29 | $1.86B derived: sum of 2 quarters · filed 2026-02-17 | $2.74B derived: sum of 3 quarters · filed 2026-02-17 | $3.63B derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $931.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $1.81B derived: sum of 2 quarters · filed 2026-02-17 | $2.70B derived: sum of 3 quarters · filed 2026-02-17 | $3.59B 10-K · filed 2026-02-17 |
| 2023-09-30 | $877.00M 10-Q · filed 2024-10-29 | $1.77B derived: sum of 2 quarters · filed 2024-10-29 | $2.66B 10-Q · filed 2024-10-29 | $3.52B derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $891.00M 10-Q · filed 2024-07-30 | $1.78B 10-Q · filed 2024-07-30 | $2.64B derived: sum of 3 quarters · filed 2025-02-18 | $3.46B derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $891.00M 10-Q · filed 2024-04-30 | $1.75B derived: sum of 2 quarters · filed 2025-02-18 | $2.57B derived: sum of 3 quarters · filed 2025-02-18 | $3.38B derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $860.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $1.68B derived: sum of 2 quarters · filed 2025-02-18 | $2.49B derived: sum of 3 quarters · filed 2025-02-18 | $3.27B 10-K · filed 2025-02-18 |
| 2022-09-30 | $817.00M 10-Q · filed 2023-10-30 | $1.63B derived: sum of 2 quarters · filed 2023-10-30 | $2.41B 10-Q · filed 2023-10-30 | $3.25B derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-06-30 | $811.00M 10-Q · filed 2023-07-31 | $1.60B 10-Q · filed 2023-07-31 | $2.43B derived: sum of 3 quarters · filed 2024-02-16 | $3.26B derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-03-31 | $785.00M 10-Q · filed 2023-04-28 | $1.62B derived: sum of 2 quarters · filed 2024-02-16 | $2.45B derived: sum of 3 quarters · filed 2024-02-16 | $3.31B derived: sum of 4 quarters · filed 2024-02-16 |
| 2021-12-31 | $838.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $1.67B derived: sum of 2 quarters · filed 2024-02-16 | $2.52B derived: sum of 3 quarters · filed 2024-02-16 | $3.33B 10-K · filed 2024-02-16 |
| 2021-09-30 | $827.00M 10-Q · filed 2022-10-28 | $1.69B derived: sum of 2 quarters · filed 2022-10-28 | $2.49B 10-Q · filed 2022-10-28 | $3.31B derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $859.00M 10-Q · filed 2022-07-29 | $1.66B 10-Q · filed 2022-07-29 | $2.49B derived: sum of 3 quarters · filed 2023-02-21 | $3.27B derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $804.00M 10-Q · filed 2022-04-29 | $1.63B derived: sum of 2 quarters · filed 2023-02-21 | $2.41B derived: sum of 3 quarters · filed 2023-02-21 | $3.02B derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $824.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $1.61B derived: sum of 2 quarters · filed 2023-02-21 | $2.22B derived: sum of 3 quarters · filed 2023-02-21 | $2.98B 10-K · filed 2023-02-21 |
| 2020-09-30 | $784.00M 10-Q · filed 2021-10-29 | $1.40B derived: sum of 2 quarters · filed 2021-10-29 | $2.16B 10-Q · filed 2021-10-29 | $2.96B derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-06-30 | $611.00M 10-Q · filed 2021-07-30 | $1.37B 10-Q · filed 2021-07-30 | $2.18B derived: sum of 3 quarters · filed 2022-02-18 | $2.94B derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-03-31 | $763.00M 10-Q · filed 2021-04-30 | $1.57B derived: sum of 2 quarters · filed 2022-02-18 | $2.33B derived: sum of 3 quarters · filed 2022-02-18 | $3.08B derived: sum of 4 quarters · filed 2022-02-18 |
| 2019-12-31 | $803.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $1.56B derived: sum of 2 quarters · filed 2022-02-18 | $2.32B derived: sum of 3 quarters · filed 2022-02-18 | $3.06B 10-K · filed 2022-02-18 |
| 2019-09-30 | $760.00M 10-Q · filed 2020-10-30 | $1.51B derived: sum of 2 quarters · filed 2020-10-30 | $2.25B 10-Q · filed 2020-10-30 | $3.01B derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-06-30 | $753.00M 10-Q · filed 2020-08-03 | $1.49B 10-Q · filed 2020-08-03 | $2.25B derived: sum of 3 quarters · filed 2021-02-19 | $2.98B derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-03-31 | $741.00M 10-Q · filed 2020-05-04 | $1.50B derived: sum of 2 quarters · filed 2021-02-19 | $2.22B derived: sum of 3 quarters · filed 2021-02-19 | $2.97B derived: sum of 4 quarters · filed 2021-02-19 |
| 2018-12-31 | $756.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $1.48B derived: sum of 2 quarters · filed 2021-02-19 | $2.23B derived: sum of 3 quarters · filed 2021-02-19 | $3.00B 10-K · filed 2021-02-19 |
| 2018-09-30 | $726.00M 10-Q · filed 2019-11-04 | $1.47B derived: sum of 2 quarters · filed 2019-11-04 | $2.25B 10-Q · filed 2019-11-04 | |
| 2018-06-30 | $748.00M 10-Q · filed 2019-08-05 | $1.52B 10-Q · filed 2019-08-05 | ||
| 2018-03-31 | $774.00M 10-Q · filed 2019-04-29 | |||
| 2017-12-31 | $3.08B 10-K · filed 2020-02-24 | |||
| 2016-12-31 | $3.12B 10-K · filed 2019-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Surgery Partners, Inc. (SGRY) | United States | $1.860B | -24.80 |
| Ardent Health, Inc. (ARDT) | United States | $1.478B | 17.91 |
| COMMUNITY HEALTH SYSTEMS INC (CYH) | United States | $0.405B | 1.87 |
| HCA Healthcare, Inc. (HCA) | United States | $93.934B | 15.49 |